African Trypanosomiasis - Pipeline Review, H2 2013

Market: Pharmaceuticals and Healthcare

Global, 48 pages report, published by Global Markets Direct

Keywords : African Trypanosomiasis Therapeutic Products under Development, Key Players in African Trypanosomiasis Therapeutics, African Trypanosomiasis Pipeline Overview, African Trypanosomiasis Pipeline, African Trypanosomiasis Pipeline Assessment

Report ThumbnailSeptember-2013
African Trypanosomiasis - Pipeline Review, H2 2013

Summary

Global Markets Direct’s, 'African Trypanosomiasis - Pipeline Review, H2 2013', provides an overview of the indication’s therapeutic pipeline. This report provides information on the therapeutic development for African Trypanosomiasis, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for African Trypanosomiasis. African Trypanosomiasis - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- A snapshot of the global therapeutic scenario for African Trypanosomiasis.
- A review of the African Trypanosomiasis products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the African Trypanosomiasis pipeline on the basis of route of administration and molecule type.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- Identify and understand important and diverse types of therapeutics under development for African Trypanosomiasis.
- Identify emerging players with potentially strong product portfolio and design effective counter-strategies to gain competitive advantage.
- Plan mergers and acquisitions effectively by identifying players of the most promising pipeline.
- Devise corrective measures for pipeline projects by understanding African Trypanosomiasis pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline.
  • List of Figures
  • Number of Products under Development for African Trypanosomiasis, H2 2013 7
  • Products under Development for African Trypanosomiasis - Comparative Analysis, H2 2013 8
  • Products under Development by Companies, H2 2013 9
  • Products under Investigation by Universities/Institutes, H2 2013 10
  • Early Clinical Stage Products, H2 2013 11
  • Discovery and Pre-Clinical Stage Products, H2 2013 12
  • Assessment by Monotherapy Products, H2 2013 20
  • Assessment by Route of Administration, H2 2013 21
  • Assessment by Stage and Route of Administration, H2 2013 22
  • Assessment by Molecule Type, H2 2013 23
  • Assessment by Stage and Molecule Type, H2 2013 24
  • List of Tables
  • Number of Products Under Development for African Trypanosomiasis, H2 2013 7
  • Products under Development for African Trypanosomiasis - Comparative Analysis, H2 2013 8
  • Number of Products under Development by Companies, H2 2013 9
  • Number of Products under Investigation by Universities/Institutes, H2 2013 10
  • Comparative Analysis by Early Clinical Stage Development, H2 2013 11
  • Comparative Analysis by Discovery and Pre-Clinical Stage Development, H2 2013 12
  • Products under Development by Companies, H2 2013 13
  • Products under Investigation by Universities/Institutes, H2 2013 14
  • Genzyme Corporation, H2 2013 15
  • Sanofi-Aventis, H2 2013 16
  • D-Pharm Ltd., H2 2013 17
  • Anacor Pharmaceuticals, Inc., H2 2013 18
  • aRigen Pharmaceuticals, Inc., H2 2013 19
  • Assessment by Monotherapy Products, H2 2013 20
  • Assessment by Stage and Route of Administration, H2 2013 22
  • Assessment by Stage and Molecule Type, H2 2013 24
  • African Trypanosomiasis Therapeutics - Drug Profile Updates 41
  • African Trypanosomiasis Therapeutics - Discontinued Products 43
  • Table of Contents
  • Table of Contents 2
  • List of Tables 4
  • List of Figures 4
  • Introduction 5
  • Global Markets Direct Report Coverage 5
  • African Trypanosomiasis Overview 6
  • Therapeutics Development 7
  • An Overview of Pipeline Products for African Trypanosomiasis 7
  • African Trypanosomiasis Therapeutics under Development by Companies 9
  • African Trypanosomiasis Therapeutics under Investigation by Universities/Institutes 10
  • Early Clinical Stage Products 11
  • Comparative Analysis 11
  • Discovery and Pre-Clinical Stage Products 12
  • Comparative Analysis 12
  • African Trypanosomiasis Therapeutics - Products under Development by Companies 13
  • African Trypanosomiasis Therapeutics - Products under Investigation by Universities/Institutes 14
  • Companies Involved in African Trypanosomiasis Therapeutics Development 15
  • Genzyme Corporation 15
  • Sanofi-Aventis 16
  • D-Pharm Ltd. 17
  • Anacor Pharmaceuticals, Inc. 18
  • aRigen Pharmaceuticals, Inc. 19
  • African Trypanosomiasis - Therapeutics Assessment 20
  • Assessment by Monotherapy Products 20
  • Assessment by Route of Administration 21
  • Assessment by Molecule Type 23
  • Drug Profiles 25
  • DP-460 - Drug Profile 25
  • Product Description 25
  • Mechanism of Action 25
  • R&D Progress 25
  • DP-b99 - Drug Profile 26
  • Product Description 26
  • Mechanism of Action 26
  • R&D Progress 26
  • ARA-01 - Drug Profile 29
  • Product Description 29
  • Mechanism of Action 29
  • R&D Progress 29
  • AN-3520 - Drug Profile 30
  • Product Description 30
  • Mechanism of Action 30
  • R&D Progress 30
  • SCYX-6759 - Drug Profile 31
  • Product Description 31
  • Mechanism of Action 31
  • R&D Progress 31
  • AN-5568 - Drug Profile 32
  • Product Description 32
  • Mechanism of Action 32
  • R&D Progress 32
  • Neglected Diseases Program - Drug Profile 34
  • Product Description 34
  • Mechanism of Action 34
  • R&D Progress 34
  • N-Myristoyltransferase Inhibitor - Drug Profile 35
  • Product Description 35
  • Mechanism of Action 35
  • R&D Progress 35
  • Drug For African Trypanosomiasis - Drug Profile 36
  • Product Description 36
  • Mechanism of Action 36
  • R&D Progress 36
  • GENZ-644131 - Drug Profile 37
  • Product Description 37
  • Mechanism of Action 37
  • R&D Progress 37
  • Nitrobenzyl Phosphoramide Mustards - Drug Profile 38
  • Product Description 38
  • Mechanism of Action 38
  • R&D Progress 38
  • 6-Methoxy Gossypol - Drug Profile 39
  • Product Description 39
  • Mechanism of Action 39
  • R&D Progress 39
  • 6,6-Dimethoxy Gossypol - Drug Profile 40
  • Product Description 40
  • Mechanism of Action 40
  • R&D Progress 40
  • African Trypanosomiasis Therapeutics - Drug Profile Updates 41
  • African Trypanosomiasis Therapeutics - Discontinued Products 43
  • African Trypanosomiasis - Product Development Milestones 44
  • Featured News & Press Releases 44
  • Aug 19, 2013: Positive Results for D-Pharm's Investigational Drugs in Models of Human African Trypanosomiasis and Malaria 44
  • Mar 12, 2012: Anacor Announces Commencement Of Phase I Clinical Trials Of Boron-Based Compound For Sleeping Sickness 44
  • Jun 28, 2011: Anacor Pharmaceuticals Partnership Advances New Drug Candidate To Combat Sleeping Sickness 45
  • Appendix 47
  • Methodology 47
  • Coverage 47
  • Secondary Research 47
  • Primary Research 47
  • Expert Panel Validation 47
  • Contact Us 48
  • Disclaimer 48

Please select a license type

Share

Related Products

Global Markets DirectAfrican Trypanosomiasis - Pipeline Review, H2 2013Product ThumbnailAfrican Trypanosomiasis - Pipeline Review, H2 2013, Industry ReportProduct #: 113331
GlobalData
TeleResearch
Global Markets Direct
GBI Research
MarketsandMarkets
MicroMarketMonitor
PayPal Acceptance Mark
SSL Certificate
Copyright © 2017 Global Market Analyst. All Rights Reserved